Skip to Main Content

Paper Details

In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19.
J Antimicrob Chemother
72
2021
Author NameAffiliation
Dinshaw J PatelMemorial Sloan-Kettering Cancer Center
  • 1 - 1

Datasets

Release 1.2